These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 6811832)
21. Open trial of mesoglycan in the treatment of cerebrovascular ischemic disease. Mansi D; Sinisi L; De Michele G; Di Geronimo G; Palma V; Brescia Morra V; Coppola N; Buscaino GA Acta Neurol (Napoli); 1988 Apr; 10(2):108-12. PubMed ID: 2969172 [No Abstract] [Full Text] [Related]
22. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day]. Piguet PV; Zoufal Z Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453 [No Abstract] [Full Text] [Related]
23. Design aspects of clinical trials with ergot alkaloids: a comparison of two geriatric behavioral rating scales. Yesavage JA; Adey M Adv Biochem Psychopharmacol; 1980; 23():357-62. PubMed ID: 7395622 [No Abstract] [Full Text] [Related]
29. [Dihydroergocristine. Recent research and development]. Arzneimittelforschung; 1992 Nov; 42(11A):1379-421. PubMed ID: 1492855 [No Abstract] [Full Text] [Related]
30. [Comparison of subjective tolerance of hydergine specific and hydergine in gerontologic therapy]. Ronge J; Dennler HJ Med Welt; 1982 Oct; 33(42):1485-9. PubMed ID: 6757638 [No Abstract] [Full Text] [Related]
31. [The effect of dihydroergocristine by intra-arterial injection. Experimental study with hyperselective catheterisation (author's transl)]. Bories J; Merland JJ; Thiebot J Ann Radiol (Paris); 1977 Jun; 20(5):531-8. PubMed ID: 409329 [No Abstract] [Full Text] [Related]
32. A multidimensional approach to the assessment of clinical validity in a study on CCVD treatment: dihydroergocristine versus placebo. Fioravanti M; Buckley AE; Agnoli A Arch Gerontol Geriatr; 1987 Apr; 6(1):83-93. PubMed ID: 3109340 [TBL] [Abstract][Full Text] [Related]
33. [Thrombolytic therapy of cerebrovascular disorders]. Estol CJ Rev Neurol; 1999 Dec 16-31; 29(12):1301-9. PubMed ID: 10652760 [TBL] [Abstract][Full Text] [Related]
34. [Hypertension in old age. Treatment with Hydergin]. Dennler HJ; Weidinger G ZFA (Stuttgart); 1983 Oct; 59(29):1646-9. PubMed ID: 6359752 [No Abstract] [Full Text] [Related]
35. Rhucin, a recombinant C1 inhibitor for the treatment of hereditary angioedema and cerebral ischemia. Longhurst H Curr Opin Investig Drugs; 2008 Mar; 9(3):310-23. PubMed ID: 18311668 [TBL] [Abstract][Full Text] [Related]
36. [The current state of citicholine in cerebral ischemia]. Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748 [TBL] [Abstract][Full Text] [Related]
37. Dihydroergocristine. Recent research and development. Mailland F Arzneimittelforschung; 1992 Nov; 42(11A):1379-80. PubMed ID: 1492856 [No Abstract] [Full Text] [Related]
38. [Efficacy of the combination drug vasobral in chronic vascular encephalopathy]. Levin OS; Barantsevich ER; Belskaya GN; Vasenina EE; Kopishinskaya SV; Lukashevich IG; Ostroumova OD; Psokhina OV; Radiuk MA Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):25-9. PubMed ID: 25591512 [TBL] [Abstract][Full Text] [Related]
39. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics]. Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587 [No Abstract] [Full Text] [Related]
40. [Delay in the treatment of cerebral ischemia]. Fogelholm R Duodecim; 1996; 112(1):65-6. PubMed ID: 10590606 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]